Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection

AIDS

Volumn 27, Issue 11, 2013, Pages 1735-1742

  Unemori, Patrick ^a   Leslie, Kieron S ^a   Hunt, Peter W ^b   Sinclair, Elizabeth ^b   Epling, Lorrie ^b   Mitsuyasu, Ronald ^c   Effros, Rita B ^c   Dock, Jeffrey ^c   Dollard, Sheila G ^d   Deeks, Steven G ^b   Martin, Jeffrey N ^e   Maurer, Toby A ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CCR5; CD28; CD57; immunosenescence; Kaposi's sarcoma; senescence

Indexed keywords

CD28 ANTIGEN; CD38 ANTIGEN; CD57 ANTIGEN; CHEMOKINE RECEPTOR CCR5; HLA DR ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGING; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; STABLE EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; ANTIGENS, CD; CASE-CONTROL STUDIES; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; SARCOMA, KAPOSI; T-LYMPHOCYTES;

EID: 84879884046     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283601144     Document Type: Article

References (27)

1. Abbaszadeh S, Taheri S. Kaposi's sarcoma after renal transplantation. Saudi J Kidney Dis Transpl 2009; 20:775-778.
2. Aronovitch SA. Dermatological management of Kaposi sarcoma. Dermatol Nurs 1995; 7:191-195.
3. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002; 94:1204-1210.
4. Gallafent JH, Buskin SE, De Turk PB, Aboulafia DM. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol 2005; 23:1253-1260.
5. Serraino D, De Paoli A, Zucchetto A, Pennazza S, Bruzzone S, Spina M, et al. The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era. Cancer Epidemiol 2010; 34:257-261.
6. Polesel J, Franceschi S, Suligoi B, Crocetti E, Falcini F, Guzzinati S, et al. Cancer incidence in people with AIDS in Italy. Int J Cancer 2010; 127:1437-1445.
7. Maurer T, Ponte M, Leslie K. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med 2007; 357:1352-1353.
8. Appay V, Almeida JR, Sauce D, Autran B, Papagno L. Accelerated immune senescence and HIV-1 infection. Exp Gerontol 2007; 42:432-437.
9. Appay V, Papagno L, Spina CA, Hansasuta P, King A, Jones L, et al. Dynamics of T cell responses in HIV infection. J Immunol 2002; 168:3660-3666.
10. Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R, et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 2005; 79:14169-14178.
11. Le Priol Y, Puthier D, Lecureuil C, Combadiere C, Debre P, Nguyen C, et al. High cytotoxic and specific migratory potencies of senescent CD8R CD57R cells in HIV-infected and uninfected individuals. J Immunol 2006; 177:5145-5154.
12. Pommier JP, Gauthier L, Livartowski J, Galanaud P, Boue F, Dulioust A, et al. Immunosenescence in HIV pathogenesis. Virology 1997; 231:148-154.
13. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009; 15:955-959.
14. Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, et al. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 2011; 203:452-463.
15. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8R T cells. Blood 2003; 101:2711-2720.
16. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30:e47.
17. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-2015.
18. Pau CP, Lam LL, Spira TJ, Black JB, Stewart JA, Pellett PE, et al. Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 1998; 36:1574-1577.
19. Dollard SC, Nelson KE, Ness PM, Stambolis V, Kuehnert MJ, Pellett PE, et al. Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort. Transfusion 2005; 45:500-503.
20. Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, et al. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 2003; 43:1260-1268.
21. Cannon MJ, Operskalski EA, Mosley JW, Radford K, Dollard SC. Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort. J Infect Dis 2009; 199:1592-1598.
22. Lin J, Epel E, Cheon J, Kroenke C, Sinclair E, Bigos M, et al. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods 2010; 352:71-80.
23. Navenot JM, Wang ZX, Trent JO, Murray JL, Hu QX, DeLeeuw L, et al. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II binding. J Mol Biol 2001; 313:1181-1193.
24. Shao W, Fernandez E, Sachpatzidis A, Wilken J, Thompson DA, Schweitzer BI, et al. CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure. Eur J Biochem 2001; 268:2948-2959.
25. Nicholas J, Ruvolo VR, Burns WH, Sandford G, Wan X, Ciufo D, et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 1997; 3:287-292.
26. Nakano K, Isegawa Y, Zou P, Tadagaki K, Inagi R, Yamanishi K. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells. Arch Virol 2003; 148:871-890.
27. Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008; 47:542-553.